Chris Walsh is co-founder and CEO of Tile Bio, a cutting-edge digital pathology company building AI systems to transform cancer diagnosis and treatment and revolutionise biomarker target discovery and validation in pharmaceutical research. A researcher in AI for cancer science, Chris develops self-learning algorithms to interpret histology and unlock clinically relevant insights from whole slide images. His work bridges deep learning innovation with translational impact in oncology.
Christopher Walsh
Co-founder and CEO at Tile Bio
For general conference and registration enquires please contact the below email id or via call
Login 
Thursday - May 29, 2025
02:35
PM -
03:00
PM 
25
Minutes
info@corvusglobalevents.com
+44
(0)
207
096 0786
